Clinical Trial Update: Efficacy and the Safety of Insulin Detemir in Subjects With Insulin Requiring Diabetes [Phase 3]

View source ↗

Summary

This Phase 3 trial update reports the efficacy and safety of insulin detemir in subjects requiring insulin, including Type 1 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Levemir (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED